beta, beta-dimethylacrylshikonin has been researched along with Colorectal Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, Y; Feng, T; He, J; Jin, S; Li, H; Shao, Z; Yan, J | 1 |
1 other study(ies) available for beta, beta-dimethylacrylshikonin and Colorectal Cancer
Article | Year |
---|---|
Effect of β,β-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Nude; Naphthoquinones; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2012 |